Keywords: lexapro, namenda, help, forest, income, fiscal, 3rd-qtr

Lexapro and Namenda help Forest's income for fiscal 3rd-qtr soar 21%, beating estimates

Article | 21 January 2008

Print This

US drugmaker Forest Laboratories says that higher sales helped boost earnings in its fiscal third quarter ended December 2007. Net income ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in